Search results
Results will auto-populate based on filter selection.
Found 256 result(s)
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
Indication(s)Symptomatic relief of major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain associated with diabetic peripheral neuropathy (DPN…
On this page: Background Purpose Application and Scope Policy Statement…
Indication(s)Benzodiazepines are indicated in a treatment of a variety of disorders (depending on their pharmacokinetic profile and evidence), including anxiety disorder,…
Note: This is not a policy; it is a supplementary document to illustrate how the WSIB will administer the Workplace Safety and Insurance Act, 1997, (WSIA) and Policies…
We want people with hearing loss to receive quality devices and services to improve their quality of life.We value our relationship with audiologists and hearing instrument…
Comprehensive benefits, services and programsSmall businesses enjoy a number of services and programs and comprehensive benefits for their workers. We also have several…
The WSIB creates Administrative Practice Documents when we determine there is a need for a supplementary document to assist in understanding the practical application of…
Indication(s)The treatment of schizophrenia and related psychotic disorders, manic or mixed episodes in bipolar I disorder, and for use as an adjunct to antidepressants for…
The mental health program of care is a contracted, community-based mental health care program. Through the program, people with claims will have access to timely assessment…
The WSIB is where potential meets purpose. To reach our potential and live up to our purpose, we’re building an inclusive work environment that reflects the people we serve.…
Indication(s)The relief of moderate to severe pain in adults who require continuous opioid analgesia for several days or more. The naloxone component is indicated for the…
The WSIB carried out a policy consultation on the core rate framework policies from August 2017 to January 2018. The feedback received was valuable and helped to inform the…
Vision and commitment We are committed to meeting the requirements outlined in the Accessibility for Ontarians with Disabilities Act (AODA), and: treating all people in a…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
On this page: Key principles Definitions Introduction Initial…
On this page: Introduction Background The consultation process Summary…
Our new premium rate-setting model is replacing existing experience rating programs. Businesses will receive their final NEER and CAD-7 statements in the fall of 2020.…
Policy’s 2024 year in reviewWhat did we accomplish?In 2024, our Policy and Consultation Services team continued to make our policies easier to understand and apply,…
Note: This is not a policy; it is supplementary information to illustrate how the WSIB will administer the Workplace Safety and Insurance Act, 1997, (WSIA) and…
The WSIB has concluded a review of the rate setting approach for temporary employment agencies (TEAs). The review was in response to concerns raised by a subset of businesses…
Indication(s)Treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and obsessive compulsive disorder (OCD).Formulary statusThe Drug Advisory…